Kathleen Rickard
Chief Tech/Sci/R&D Officer at VERONA PHARMA PLC
Net worth: 17 M $ as of 2024-03-30
Profile
Kathleen Rickard is currently the Chief Medical Officer at Verona Pharma Plc since 2019.
Prior to this, she worked at Aerocrine AB from 2011 to 2019 as the Chief Medical & Compliance Officer.
She also worked at GSK Plc as the VP-Clinical Development & Medical Affairs.
Dr. Rickard holds a doctorate degree from Hahnemann University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERONA PHARMA PLC
1.80% | 2024-02-04 | 8,656,336 ( 1.80% ) | 17 M $ | 2024-03-30 |
Kathleen Rickard active positions
| Companies | Position | Start |
|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 2019-01-31 |
Former positions of Kathleen Rickard
| Companies | Position | End |
|---|---|---|
| AEROCRINE AB | Compliance Officer | 2018-12-31 |
| GSK PLC | Corporate Officer/Principal | - |
Training of Kathleen Rickard
| Hahnemann University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
- Stock Market
- Insiders
- Kathleen Rickard
